PF-ILD is a suspected infectious disease in the field of respiratory digestive and endocrine disorders. Clinical performance is complex and often involves multiple systemic strain. Early identification and standardized diagnosis are essential for improving prognosis.
The diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation. The platform can assist in linking teams of domestic and foreign authoritative experts to provide accurate diagnosis and treatment programs. Treatment and management of PF-ILD requires individual development of treatment programs, usually including pharmacotherapy, rehabilitation interventions, regular follow-up, and other multidimensional management.
In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many infectious respiratory digestive endocrine disorders that were previously difficult to treat have been significantly improved. Therapeutic efficacy and adverse reactions need to be closely monitored and timely adjusted according to changes in the course of treatment. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of PF-ILD-associated lower extremity diarrhoea.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of changes in conditions and treatment effects.